financetom
Business
financetom
/
Business
/
Acuity Brands Fiscal Fourth-Quarter Results Top Street Views
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Acuity Brands Fiscal Fourth-Quarter Results Top Street Views
Oct 1, 2024 5:23 PM

11:06 AM EDT, 10/01/2024 (MT Newswires) -- Acuity Brands ( AYI ) on Tuesday reported fiscal fourth-quarter results that topped market estimates as the company's intelligent spaces segment saw double-digit revenue growth.

Adjusted earnings came in at $4.30 per share for the quarter ended August, up from $3.97 the year before, according to the provider of lighting and building management solutions. The consensus on Capital IQ was for normalized EPS of $4.20. Sales increased 2.2% year over year to $1.03 billion, ahead of the Street's view for $1.01 billion.

"Our fiscal 2024 fourth quarter performance was strong," Chief Executive Neil Ashe said in a statement. "We grew net sales in both lighting and spaces, delivered margin expansion and increased earnings per share." The stock increased 4.8% in Tuesday trading.

Sales in the brands lighting and lighting controls segment rose 1.1% year over year to $955 million. The increase was driven by improvements across most of the company's channels, but mainly due to higher sales in its corporate accounts business, Chief Financial Officer Karen Holcom said on an earnings call, according to a Capital IQ transcript.

Revenue in the intelligent spaces group business climbed about 17% to $83.9 million amid growth in the company's Distech Controls energy management solutions unit on the back of data center projects, according to Holcom.

Operating profit as a percentage of sales rose roughly 430 basis points to 15.2% during the quarter. Selling, distribution and administrative expenses rose to $331.7 million from $313 million last year, the company said.

Acuity anticipates adjusted EPS to be in a range of $16 to $17.50 for fiscal 2025 and sales between $3.9 billion to $4.1 billion, Holcom said on the call. The Street is looking for revenue of $3.99 billion in the period while one analyst on Capital IQ expects normalized earnings of $16.40 per share. In its just-ended fiscal year, the company's adjusted EPS advanced 11% to $15.56, while sales decreased 3% to $3.84 billion.

Revenue in the brands lighting and lighting controls division is forecast to rise by low- to mid-single-digits, according to Holcom. The company also estimates "low- to mid-teens" sales growth in the intelligent spaces unit, the CFO told analysts.

Price: 286.86, Change: +11.47, Percent Change: +4.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Premier American Uranium Completes Acquisition of Nuclear Fuels
Premier American Uranium Completes Acquisition of Nuclear Fuels
Sep 16, 2025
TORONTO, Sept. 16, 2025 /PRNewswire/ - Premier American Uranium Inc. ( PAUIF ) (PUR or Premier American Uranium) (TSXV: PUR)  and Nuclear Fuels Inc. ( NFUNF ) (NF or Nuclear Fuels) (CSE: NF) are pleased to announce the completion of the previously announced arrangement (the Arrangement) whereby Premier American Uranium ( PAUIF ) has acquired all of the issued and...
The Ether Machine Announces Confidential Submission of a Draft Registration Statement on Form S-4 with the SEC
The Ether Machine Announces Confidential Submission of a Draft Registration Statement on Form S-4 with the SEC
Sep 16, 2025
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Ether Machine, a planned public company following a pending business combination with Dynamix Corporation ( ETHM ) (“Dynamix”) and The Ether Reserve LLC, announced today the confidential submission by The Ether Machine of a draft registration statement on Form S-4 with the U.S. Securities and Exchange Commission (the “SEC”).  Andrew Keys,...
Market Chatter: Eli Lilly's Weight-Loss Pill May Get FDA Approval by Year-End
Market Chatter: Eli Lilly's Weight-Loss Pill May Get FDA Approval by Year-End
Sep 16, 2025
07:43 AM EDT, 09/16/2025 (MT Newswires) -- Eli Lilly's ( LLY ) investigational oral weight-loss drug orforglipron could be approved by the US Food and Drug Administration before the end of the year under a new one-to-two-month priority review process, Reuters reported Tuesday, citing Wall Street analysts. Analysts see the drug as a strong candidate for the fast-track program, which...
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™
Sep 16, 2025
SAN FRANCISCO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Medicines360, a women’s health innovation organization with a mission to be a catalyst for change, today announced that it has acquired global licensing rights to PeriPeach, an investigational medical device designed to prevent severe perineal tears during birth, from Fruits of Labor, Inc. PeriPeach will now advance through the 360 Innovation Hub,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved